Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
4(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_4
6
50%
Ph not_applicable
2
17%
Ph phase_1
1
8%
Ph phase_3
2
17%

Phase Distribution

1

Early Stage

1

Mid Stage

8

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
2(16.7%)
Phase 4Post-market surveillance
6(50.0%)
N/ANon-phased studies
2(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

12

all time

Status Distribution
Active(5)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting2
Active, not recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 21 (8.3%)
Phase 32 (16.7%)
Phase 46 (50.0%)
N/A2 (16.7%)

Trials by Status

completed433%
not_yet_recruiting18%
recruiting217%
unknown325%
active_not_recruiting217%

Recent Activity

4 active trials
Showing 5 of 12
active_not_recruitingphase_4

Atorvastatin Effect on Reduction of COPD Exacerbations

NCT04789057
not_yet_recruitingphase_4

Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

NCT07508254
recruitingphase_4

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

NCT04262206
recruitingphase_3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

NCT06360120
active_not_recruitingphase_4

Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

NCT05586750
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT04789057Phase 4

Atorvastatin Effect on Reduction of COPD Exacerbations

Active Not Recruiting
NCT07508254Phase 4

Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

Not Yet Recruiting
NCT04262206Phase 4

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting
NCT06360120Phase 3

Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

Recruiting
NCT05586750Phase 4

Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

Active Not Recruiting
NCT05946122Phase 1

Effect of Atorvastatin as a Renal Protection in Patients With Systemic Inflammatory Response Syndrome Using Renal Arterial Resistive Index

Unknown
NCT05806723Phase 4

Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men

Completed
NCT05792293Phase 2

Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity

Unknown
NCT05730634Not Applicable

The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT

Completed
NCT05306990Not Applicable

Statins in Patients With Type 2 Diabetes Mellitus and Previous History of Acute Coronary Syndrome

Completed
NCT04952350Phase 3

Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT

Unknown
NCT03784703Phase 4

Type 2 Diabetic Patients Maintained on Statin Therapy

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12